A Novel Allosteric Mechanism on Protein–DNA Interactions underlying the Phosphorylation-Dependent Regulation of Ets1 Target Gene Expressions  by Shiina, Masaaki et al.
ArticleMasaaki Shiina0022-2836/© 2014 The
(http://creativecommons.oA Novel Allosteric Mechanism on
Protein–DNA Interactions underlying the
Phosphorylation-Dependent Regulation of
Ets1 Target Gene Expressions1, 2, Keisuke Hamada1, 2, Taiko Inoue-Bungo1, †,
Mariko Shimamura1, †, Akiko Uchiyama1, †, Shiho Baba1, Ko Sato1,
Masaki Yamamoto2, 3 and Kazuhiro Ogata1, 2
1 - Department of Biochemistry, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku,
Yokohama 236-0004, Japan
2 - RIKEN SPring-8 Center, 1-1-1 Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5148, Japan
3 - SPring-8/JASRI, 1-1-1 Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5198, JapanCorrespondence to Kazuhiro Ogata: Department of Biochemistry, Yokohama City University Graduate School of
Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. ogata@med.yokohama-cu.ac.jp
http://dx.doi.org/10.1016/j.jmb.2014.07.020
Edited by J. BergerAbstract
Cooperative assemblies of transcription factors (TFs) on target gene enhancers coordinate cell proliferation,
fate specification, and differentiation through precise and complicated transcriptional mechanisms. Chemical
modifications, such as phosphorylation, of TFs induced by cell signaling further modulate the dynamic
cooperativity of TFs. In this study, we found that various Ets1-containing TF–DNA complexes respond
differently to calcium-induced phosphorylation of Ets1, which is known to inhibit Ets1–DNA binding.
Crystallographic analysis of a complex comprising Ets1, Runx1, and CBFβ at the TCRα enhancer revealed
that Ets1 acquires robust binding stability in the Runx1 and DNA-complexed state, via allosteric mechanisms.
This allows phosphorylated Ets1 to be retained at the TCRα enhancer with Runx1, in contrast to other Ets1
target gene enhancers including mb-1 and stromelysin-1. This study provides a structure-based model for
cell-signaling-dependent regulation of target genes, mediated via chemical modification of TFs.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The specificity of transcriptional regulation is deter-
mined by transcription factor (TF) complexes, formed
on cis-acting DNA regulatory elements within enhanc-
er regions [1–3]. The activity and localization of each
TF as a component of such regulatory complexes is
controlled by various cell signals, via the chemical
modification of TFs. TF phosphorylation/dephosphor-
ylation is an important modification, which plays a role
in the regulation of nuclear transport [4,5], homo-
multimerization [6,7], interactions with coactivators
[8,9], andDNA binding [10–12]. However, the effect of
TF phosphorylation in the context of functional high-
er-order TF assemblies on target enhancers remains
largely unknown at the atomic level.Authors. Published by Elsevier Ltd. This
rg/licenses/by-nc-nd/3.0/).The binding specificity of many TFs to their target
promoters/enhancers is determined by partnership
with other TFs. For example, the v-ets erythroblastosis
virus E26 oncogene homolog 1 (Ets1) protein regu-
lates target gene expression in cooperation with
various partner TFs [13]. Well-characterized Ets1
partners include the runt-related transcription factor 1
(Runx1)–core-binding factor β (CBFβ) heterodimer
[14], which regulates the TCRα/β genes encoding the
T cell receptor α and β chains in T cells [15,16]; paired
box 5 (Pax5), which regulates themb-1 gene encoding
the immunoglobulin-associated α chain in B cells
[17–19]; and Ets1 itself, which acts as a homodimer to
regulate the stromelysin-1 (also known as MMP-3)
gene encoding matrix metalloproteinase 3 in stromal
cells [20–22]. These partner TFs are thought to recruitis an open access article under the CC BY-NC-ND license
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1656 DNA-mediated allosteryEts1 to enhancers, thereby transactivating target
genes in a cell-specific manner. Note that, in T cells,
the latter two genes, the mb-1 and stromelysin-1, are
considered not to be a major target of Ets1.
Ets1 is a member of the Ets family of TFs, which are
characterized by a highly conserved DNA binding
domain called Ets domain. Previous studies have
shown that Ets1 plays crucial roles in a wide variety of
biological processes, including hematopoiesis, angio-
genesis, apoptosis, and tumor progression and
invasion [13]. Ets1 reportedly undergoes Ca2+/
calmodulin-dependent protein kinase II (CaMKII)-
mediated phosphorylation, resulting in Ets1–DNA
binding inhibition, which is thought to regulate T cell
function [23–26]. We have been studying Ets1-
containing, higher-order TF–DNA complexes and the
effects of Ets1 phosphorylation induced by calcium
signaling on complex formation to better understand
themechanisms underlying cooperative TF assembly.
In the present study, we identify a specific shift in
the target gene repertoire following Ets1 phosphor-
ylation. We demonstrate that the regulation of
lineage-specific transcription is controlled by the
assembly and disassembly of Ets1 and its partner
TFs on target enhancers. This process is dynami-
cally controlled by Ets1 phosphorylation, in a manner
dependent on both cis-elements and specific partner
TFs. We also used crystallographic and mutational
analyses to compare a complex containing Ets1–
Runx1–CBFβ heterodimer on the TCRα enhancer
with a complex containing Ets1–Pax5 on the mb-1
enhancer and an Ets1 homodimer complex on the
stromelysin-1 enhancer. Our findings shed novel
insights into the dynamic events underlying Ets1/
partner TF-mediated transcription upon cell signaling.Results
Crystal structure of the Ets1–Runx1–CBFβ–DNA
complex
To investigate the mechanism underlying the
cooperative binding of Ets1 and Runx1 to the
TCRα enhancer, we solved the crystal structure of
a complex composed of Ets1 (residues 276–441),
Runx1 (residues 60–263), CBFβ (residues 1–141),
and a 15-base-pair DNA fragment derived from the
TCRα enhancer at a resolution of 2.35 Å (Fig. 1a,
Fig. S1, and Table S1). The TCRα/β enhancers are
known to contain a composite binding site (Fig. S1b),
which is reportedly occupied by Ets1 and Runx1 in T
cell lines [27]. In the present structure, Ets1 and
Runx1 interact from opposite sides of the DNA helix,
across a region spanning positions 7–12. Ets1
recognizes DNA major groove using helix 3 (H3)
as previously reported and uniquely interacts with
DNA minor groove using L1 (Fig. S1d), as will bedescribed in detail later. Runx1 recognizes DNA
major groove using two loops, L3 and L12, and also
interacts with minor groove using a loop, L9 (Fig.
S1d).
Previous studies indicate that functional coopera-
tivitymaybemediated byEts1–Runx1protein–protein
interaction [15,28,29]. However, crystal structure
analysis revealed no direct Ets1–Runx1 interaction
usingEts1 (276–441) andRunx1 (60–263) fragments,
which contain regions previously reported to be
involved in this interaction (Fig. S1). Despite this
finding, cooperativity between the DNA interactions of
Ets1 and Runx1 fragments was clearly observed
(Supplementary Text; Fig. S2).
Ets1 contains an inhibitory module, which flanks the
Ets domain (seeFig. 1f for the structure andFig. S1a for
the schematic diagram) [10,30–35]. This module is
composed of a hydrophobic core (we refer to as the
inhibitory hydrophobic core in this text), surrounded by
five α helices: inhibitory helix 1 (HI-1), inhibitory helix 2
(HI-2), helix 1 (H1), helix 4 (H4), and helix 5 (H5)
(Fig. 1j). We then compared the structure of Ets1 within
an Ets1–Runx1–CBFβ–DNA complex to those in DNA
complexeswith other reportedTFpartners or in the free
state (Fig. 1 and Figs. S3a and 4) [18,19,21,22,34]. In
the context of the Ets1–Runx1–CBFβ–DNA complex,
Ets1 assumed a unique conformation in which its
regulatory region, including the inhibitory hydrophobic
core, was markedly disorganized (Fig. 1e and i, f–h,
and j–l). In particular, Tyr329, which is involved in the
hydrophobic core in free Ets1 and some Ets1-contain-
ing DNA complexes, was flipped outward, leading to a
change in the helical phase and position of HI-2
(Fig. 1e–l and Fig. S4), hereafter referred to as HI-2′
(Fig. 1e and i and Fig. S4a, e, and i). The formation of
the “rearranged” helix HI-2′was accompanied by novel
Ets1–DNA interactions between the loop L1 of Ets1
and the DNA backbone, mediated in part by van der
Waals contacts between Pro334 and a DNA sugar, as
well as a hydrogen bond between Gly333 and a DNA
phosphate (Figs. 1e, i, and m and 2a–c). In contrast,
the conformation of the inhibitory module of Ets1 in
(Ets1)2–DNAandEts1–Pax5–DNAcomplexes,which
do not contain Runx1, resembled that of free Ets1,
although HI-1 was disordered [10,19,34,36,37]. Thus,
in complexes lacking Runx1, DNA binding of Ets1
elicited only a slight change in the inhibitory hydro-
phobic core (Fig. 1f–h and j–l and Fig. S4b–d, j, and k).
The DNA conformation within these Ets1-contain-
ing complexes also differed, depending on the TF
partners bound to sites adjacent to Ets1 (Fig. 1m). In
the case of the TCRα enhancer, the DNA conforma-
tion of the Runx1-bound region within the Ets1–
Runx1–CBFβ–DNA complex was similar to that
previously observed in other Runx1-containing
DNA complexes (PDB codes 1HJB, 1HJC, and
1IO4) [38]. This suggests that Runx1 defines the
specific DNA conformation in the TCRα enhancer.
The effect of Runx1 binding to DNA extended to the
1657DNA-mediated allosteryEts1-interacting region of the DNA and, remarkably,
the DNA conformation defined by Runx1 also
affected the structure of the adjacent Ets1 loop L1
(Fig. 1e, i, and m). This is consistent with an
observation by Goetz et al., in which DNA-binding
cooperativity between Runx1 and Ets1 requires the
addition of Runx1 to DNA prior to Ets1 [29].
Meanwhile, in the mb-1 enhancer, the DNA bound
by Pax5 is spatially too close to Ets1, and in the
stromelysin-1 enhancer, DNA bound by the second
Ets1 is spatially too distant toEts1, to interactwith loop
L1 of Ets1, based on the crystal structures (Fig. 1m).
These observations indicate that, in the case of the
Ets1–Runx1–CBFβ complex formed on the TCRα
enhancer, an allosteric effect of Runx1 on Ets1,
mediated via DNA interaction, is at least in part
attributed to the cooperativity of Ets1 and Runx1 for
the DNA binding, although other mechanism may
further enhance the cooperation.
Allosteric networks in the Ets1–DNA–Runx1
interaction
Previous studies from our group and others
suggested that conformational stabilization of hydro-
gen bonds between a protein main-chain amide and a
DNAphosphate groupmay be central to the regulation
of cooperative DNA binding by TFs [3,38,39]. Stability
of a hydrogen bond between a protein main-chain
amide and a DNA phosphate is considered to depend
on precise positioning and local stability of the protein
amide group and/or the DNA phosphate group. To
distinguish effects related to the amide and the
phosphate groups, we hereafter describe the former
as the amide-directed, or A, pathway and the latter as
the phosphate-directed, or P, pathway.
Within Ets1-containing DNA complexes, the
Leu337 main-chain amide of Ets1 [L337(NH)] invari-
ably forms hydrogen bonds to a DNA backbone
phosphate [DNA(PO)], and this hydrogen bond was
reportedly facilitated by a macrodipole effect of H1 in
Ets family TFs (Fig. S1d) [39]. We therefore predicted
that this hydrogen bond may play a critical role in
regulating the Ets1–DNA interaction (Fig. 1).
Within the crystal structure of the Ets1–Runx1–
CBFβ–DNA complex, Ets1 and Runx1 interact from
opposite sides of the DNA helix, across a region
spanning positions 7–12, forming an extensive inter-
action network through the DNA (Fig. 2a and b and
Figs. S1b and S5). At the Ets1–DNA interface, the
Ets1 loop L1 recognizes the DNA helix in the minor
groove. At the Runx1–DNA interface, the Runx1 loop
L9 predominantly recognizes the minor groove, while
L12 recognizes the major groove (Fig. 2a and b). The
Runx1–DNA interaction involves a combination of van
der Waals contacts and hydrogen bonds; the side
chain of Val170 of Runx1 forms van der Waals
contacts with a DNA sugar and cytosine bases at
positions 10 and11, side chainsof Arg174andArg177form hydrogen bonds with guanine bases at positions
10 and 11 and participate in van der Waals contacts
with thymine and guanine bases at positions 9 and 10
(Fig. 2a and b), the Asp171 side chain forms hydrogen
bonds with cytosine bases at positions 10 and 11, and
the side chains of Arg139 and Lys167 and the main-
chain amides of Val170 and Gly143 form hydrogen
bonds with DNA phosphates at positions 11 and 12
(Fig. 2a and b and Fig. S5). These Runx1–DNA
interactions define the DNA structure, thereby enfor-
cing the specific conformation of Ets1 via interactions
between the DNA helix and the Ets1 loop L1 (see
Discussion). Such an interaction involves van der
Waals contacts between Gly333 and Pro334 and
DNA sugars at positions 12 and 11, as well as a
hydrogen bond between the Gly333 amide and the
DNA phosphate at position 12, as previously de-
scribed. The Ets1 loop L1 is further stabilized
intramolecularly by van der Waals contacts involving
the Pro334, Tyr329, and Ile335 side chains (Figs. 1e
and i and 2a).
Crystal lographic analysis of the mutant
Ets1(Y329A)–Runx1–CBFβ–DNA complex re-
vealed that the N-terminal region adjacent to the
Ets domain was remarkably disordered. Specifically,
contacts between Ets1 loop L1 and the DNA helix
were significantly disrupted, highlighting the contri-
bution of the abovementioned interaction network to
the maintenance of the specific Ets1 conformation
(Fig. S3b and c and Table S1). Because L337(NH) is
positioned at the boundary between L1 and H1 in
Ets1 (Figs. 1i and 2a), it is suggested that stabiliza-
tion of L1 by Runx1-bound DNA would enhance
Ets1–DNA binding by stabilizing the hydrogen bond
between L337(NH) and DNA(PO) (the A pathway)
(Fig. 2c and Fig. S6). In addition, the Runx1 Arg80
side chain forms hydrogen bonds with the guanine
base at position 8 and makes van der Waals
contacts with the thymine base at position 7. Thus,
the L337(NH) hydrogen-bonded DNA(PO) is stabi-
lized via G8:C8′ base pairing and Arg-DNA base
stacking (Fig. 2a and b). This phosphate-directed
mode of stabilizing the hydrogen bond between
L337(NH) and DNA(PO) (the P pathway) may also
enhance Ets1–DNA binding (Fig. 2c and Fig. S6).
It is assumed that the L337(NH)- and DNA(PO)-
directed interaction networks (the A and P pathways)
extending from Runx1–CBFβ to the Ets1 L337(NH)–
DNA(PO) hydrogen bond via the DNA enhancer
establish an “allosteric network” for TF–DNA assem-
bly. In this model, Runx1 likely contributes to the
specific DNA recognition of Ets1 by restricting the
DNA conformation, which results in a unique
interaction between the Ets1 loop L1 and the DNA.
Robust nature of the interaction network
To examine whether the proposed allosteric
network functions in the cooperative binding of
1658 DNA-mediated allosteryEts1 andRunx1 to the TCRα enhancer, we performed
mutational analyses on the residues involved in the A
and P pathways using electrophoretic mobility shift
assays (EMSAs). We first introduced mutations into
Ets1 (G333P, P334G, or P334Q) or Runx1 (V170A),
which are predicted to largely impair the A pathway, or
intoRunx1 (R80K), which is predicted tomainly impair
the P pathway. The wild-type or mutant Ets1 was then
titrated against DNA or the wild-type or mutant
Runx1-bound DNA. We also performed crystallo-
graphic analysis in parallel, to confirm that neither the
G333P mutation in Ets1 nor the V170A mutation in
Runx1 affected the Ets domain conformation within
the Ets1–Runx1–CBFβ–DNA complex (Table S1).Fig. 1 (legend oAs previously reported, Runx1 enhanced Ets1
binding to the TCRα enhancer ~10-fold (Fig. 3a and
Table S3). The majority of individual Ets1 or Runx1
mutations, each of which impaired only one of the
two stabilization pathways, did not appreciably affect
the cooperative DNA binding of Ets1 and Runx1.
The Ets1 P334G mutation markedly reduced the
binding of Ets1 itself (Fig. 3a, Table S3 and Fig. S7),
and therefore, the cooperativity between Ets1 and
Runx1 could not be assessed for this mutant. In
contrast, multiple mutations in Runx1 and/or Ets1
capable of impairing both the A and P pathways clearly
reduced the cooperative DNA binding of Ets1 and
Runx1 (Fig. 3a and Table S3). This suggests that bothn next page)
1659DNA-mediated allosterythe A andP pathwaysmediate allosteric regulation and
have compensatory functions within the Ets1–Runx1–
CBFβ–DNA complex, increasing the robustness of
complex stability. Mutation of other Runx1 residues
that interact with the DNA did not appreciably affect the
cooperative DNA binding of Ets1 and Runx1, although
they significantly reduced the DNA binding of Runx1
itself (Fig. S8).
Previously, Goetz et al. reported no involvement of
the DNA-mediated effect in the cooperative DNA
binding between Ets1 and Runx1, based on the
results from EMSA using a nicked DNA. They
introduced a single-strand nick in DNA at the critical
phosphate group in a composite site of Ets1 and
Runx1 to eliminate the DNA-mediated effect. They
found that the nick did not affect the cooperativity
and concluded that no DNA-mediated effect by
Runx1 works [29]. This seems contrary to our
results. However, considering that the introduction
of the DNA nick would impair the P pathway
(Fig. 3a), the effect of the DNA nick, like the R80K
mutation, may be compensated by the remaining A
pathway on the TCRα enhancer.
Stabilization pathways in other Ets1-containing
TF–DNA complexes
We next examined whether the A and P pathways
also function in other Ets1-containing TF–DNA
complexes. In the (Ets1)2–DNA complex formed on
the stromelysin-1 enhancer, two molecules of Ets1,
Ets1(A) and Ets1(B), bind to an inverted repeat of the
Ets1 binding site in a head-to-head orientation across
adjacent DNA grooves (Fig. 1c). This interaction
involves the formation of a hydrogen bond and a van
derWaals contact between themain chains of Gly333
of Ets1(A) and Asn380 of Ets1(B), as well as between
the side chains of Pro334 of Ets1(A) and Lys379 ofFig. 1. Comparison of Ets1 structures in both free and DNA-c
the Ets1–Runx1–CBFβ–DNA complex (a), free Ets1 (301–440)
[(c) PDB code 2NNY], and the Ets1 (280–440)–Pax5 (1–149)–D
orange in (a), light purple in (b), brown [Ets1(A)] and yellow [Ets1(
depicted as ribbons, arrows, and threads, respectively. The p
complex are represented by magenta (Runx1)/cyan (CBFβ) and
DNAmolecule is depicted as gray sticks. TheNMRstructure of fr
Ets1 takes a pseudodimeric formwith domain swapping of eachH
T conformer (seeDiscussion). (e–h)Magnified viewsof theEts1 s
Ets1 hydrophobic core are shown in space-filling representatio
structures in (e–h). Residues involved in the hydrophobic core
represented as black broken lines. (m) A superimposed view of
structureswere superimposedusing the least-squaresmethod to
Ets1. Within the DNA molecules, tubes indicate the DNA backb
helical axes are depicted as thick lines in theEts1–Runx1–CBFβ
(green) complexes. For simplicity, only one strand of the DNA
position 11 (see Fig. 2a for base pair positions) in the Ets1–Run
TheEts1molecules in theEts1–Runx1–CBFβ–DNAandEts1–P
colored orange and green, respectively. The side chain of Pro33
as sticks with space-filling spheres. The inset shows a close-upEts1(B) (Fig. 2d and Fig. S6b) [21,22]. These
interactions are thought to stabilize the loop L1 and,
as a result, L337(NH), via the A pathway. Previous
analysis of Ets1 binding to the stromelysin-1 enhancer
revealed that specific Ets1mutations (G333A, P334A,
or N380A) abolish cooperative DNA binding [21,22].
This indicates that the A pathway mediates cooper-
ative binding within the (Ets1)2–DNA complex (Fig. 2d
and Fig. S6b). No interaction network corresponding
to the P pathway was identified in this complex.
Analysis of the Ets1–Pax5–DNA complex formed
on themb-1 enhancer revealed that the side chain of
Gln22 in Pax5 interacts from the major groove with
DNA(PO), which is hydrogen bonded to the
L337(NH) of Ets1 in the minor groove (Figs. 1d and
2e), thereby stabilizing DNA(PO) via the P pathway
(Fig. 2e and Fig. S6c). EMSA analyses revealed that
mutation of Ets1 affecting the A pathway (G333P or
P334G) did not significantly affect cooperative DNA
binding of Ets1 and Pax5 (Fig. 3b and Table S5).
Conversely, mutation of Pax5 (Q22A) has been
previously shown to significantly impair Ets1 recruit-
ment by Pax5 [40], suggesting that the P pathway is
involved in cooperative Ets1 binding in the Ets1–
Pax5–DNA complex (Fig. 2e and Fig. S6c).
Taken together, these results suggest that coop-
erative Ets1 binding within the (Ets1)2–DNA complex
and the Ets1–Pax5–DNA complex is mediated by
the A and P pathways, respectively.
Resistance to the inhibitory effect of Ets1
phosphorylation on DNA binding
CaMKII-catalyzed phosphorylation of Ets1 in a
serine-rich region of the N-terminal extension of HI-1
is known to stabilize the inhibitory hydrophobic core
(Fig. 1b, f, and j), resulting in a 50- to 1000-fold
reduction in its affinity for DNA [12,23,37,41]. However,omplexed states. (a–d) Overviews of the crystal structures of
[(b) PDB code 1R36], the [Ets1 (280–441)]2–DNA complex
NA complex [(d) PDB code 1MDM]. Ets1 is represented by
B)] in (c), and green in (d). αHelices, β strands, and loops are
artner molecules of Ets1 in the Ets1–Runx1–CBFβ–DNA
those in the Ets1–Pax5–DNA complex in blue (Pax5). The
eeEts1 is shown instead of the crystal structure because free
I-1 in the crystal. This free Ets1 structure corresponds to the
tructures in (a–d). The side chains of residues involved in the
ns. (i–l) Schematic representations of regions of the Ets1
are shown as light-orange ovals. The hydrogen bonds are
the DNA structures in Ets1-containing DNA complexes. The
fit the amino acid region spanning residues 330–430 in each
ones, transparent sticks indicate all heavy atoms, and their
–DNA (orange), (Ets1)2–DNA (yellow), andEts1–Pax5–DNA
molecule is shown. The sugar C4′ atom of the guanine at
x1–CBFβ–DNA complex is shown as a space-filling sphere.
ax5–DNAcomplexes are shown in a superimposed viewand
4 in Ets1 in the Ets1–Runx1–CBFβ–DNA complex is shown
view of the indicated region.
Fig. 2. Interaction network amongEts1,DNA, andRunx1within theEts1–Runx1–CBFβ–DNAcomplex and its comparison
with other Ets1-containing complexes. (a and b) Front and back views of Ets1–DNA–Runx1 interactions (a) and
cross-sections at the indicated positions (b) (base pair positions are numbered according to Figs. S1b and S5). The side
chains of Tyr329, Pro334, and Ile335 in Ets1 and the side chains of Arg80, Val170, Asp171, Arg174, andArg177 inRunx1 are
shown as sticks with space-filling spheres. The Cα atom of Gly333 in Ets1 is depicted as a space-filling sphere, and the side
chains of Arg139 and Lys167 in Runx1 are shown as sticks. The numbers in circles on the DNA indicate the base pair
positions. The thymine and guanine bases at positions 7, 9, and 10; C5 of cytosine at position 10; all heavy sugar atoms of
guanine and C2′ of cytosine at position 11; and C5′ of cytosine at position 12 are shown as space-filling representations.
Hydrogen bonds are shown as dark-gray dotted lines. (c–e) Detailed views of Ets1-containing DNA complexes with
indications of the structural stabilization pathways. The A and P pathways (see the text) are depicted as blue-green and
light-purple arrows, respectively. The inset in (e) showsa close-up viewof the hydrogen bond between the side chain ofGln22
in Pax5 and a DNA phosphate in the Ets1–Pax5–DNA complex. Colors are as in Fig. 1.
1660 DNA-mediated allosterythe behavior of phosphorylated Ets1 in the presence of
partner TFs on target enhancers remains unclear. To
investigate this further, we used EMSAs to assess the
binding of unphosphorylated and phosphorylated Ets1
in the presence or absence of Runx1 to the TCRα
enhancer, Pax5 to the mb-1 enhancer, and dimeric
Ets1 to the stromelysin-1 enhancer.In the absence of partner TFs, phosphorylation of
Ets1 almost completely abolished binding to all three
enhancers [equilibrium association constant
(KA) b 1 × 10
6 M−1] (Fig. 3c–e, Fig. S9b and d,
and Tables S4 and S6). Conversely, in the presence
of Runx1, phosphorylated Ets1 was capable of
binding the TCRα enhancer with relatively high
(a) (b)
(d)
(e)(c)
Fig. 3. Mutational characterization of the cooperative DNA binding of unphosphorylated or phosphorylated Ets1 and its
partner TFs. (a–d)KA values for theDNA binding of unphosphorylated (a and b) and phosphorylated (c and d) Ets1 (276–441)
in the presence and absence of Runx1 (60–263) on the TCRα enhancer (a and c) or of Pax5 (1–149) on themb-1 enhancer
(b and d). The sequences of the DNA fragments from the TCRα and mb-1 enhancers are shown in (a) and (b). Another
Runx1 binding site adjacent to the Ets1–Runx1 composite site in the native TCRα enhancer is boxed in magenta broken
lines. This sitewas disruptedbymutagenesis because it is not involved in the cooperative bindingofEts1 andRunx1.Data are
presented as themean ± SEM (standard error of themean) (n = 3).WT, wild type; pEts1, phosphorylated Ets1; n.s., data not
shown because the DNA binding affinity was too low (KA b 1–5 × 10
6 M−1) (n.s.*) or because of cooperative binding of
multiple Ets1 molecules to the mb-1 enhancer (n.s.**) (Fig. S9c and d). (e) EMSAs showing the DNA binding of
unphosphorylated and phosphorylated Ets1 to the stromelysin-1 enhancer. The sequence of the DNA fragment and the
concentrations of Ets1 used in the titration are indicated.
1661DNA-mediated allosteryaffinity (KA = 1.1 × 10
9 M−1) (Fig. 3c, Fig. S9b
compared with a, and Table S4). In contrast,
phosphorylated Ets1 exhibited a 40-fold reduction
in binding at the mb-1 enhancer, even in the
presence of its partner TF, Pax5 (Fig. 3d, Figs. S7
and 9d compared with 9c, and Table S6). Similarly,
EMSA analysis revealed that phosphorylation of
Ets1 almost completely abolished DNA binding to
the stromelysin-1 enhancer (Fig. 3e). These findingsindicate that binding of Runx1 to the TCRα enhancer
abrogates phosphorylation-induced inhibition of
Ets1 binding to DNA. In contrast, binding of Pax5
to the mb-1 enhancer or of dimerized Ets1 to the
stromelysin-1 enhancer did not.
Importantly, in the case of the TCRα enhancer,
impairment of either A or P pathway by the introduc-
tion of a single mutation in Ets1 (G333P or P334G) or
Runx1 (V170A or R80K) (Fig. 2c and Fig. S6a)
1662 DNA-mediated allosteryabrogated cooperativeDNAbinding of phosphorylated
Ets1 with Runx1 (Fig. 3c, Fig. S7, and Table S4).
These data highlight the stability of the Ets1
complex, which is provided by the redundancy of
the A and P pathways. Such redundancy is critical
for Ets1-containing complexes to resist the inhibitory
effect of Ets1 phosphorylation on DNA binding.
The effect of Ets1 phosphorylation on target
gene transactivation
Wenext used luciferase reporter assays to examine
the effect of Ets1 phosphorylation on transactivation of
Ets1 target genes. HeLa or HEK293T cells were
co-transfected with expression plasmids encoding
Ets1 and Runx1–CBFβ or Pax5, with or without a
plasmid encoding a constitutively active CaMKII
(T287D) mutant [24,42], in addition to reporter
plasmids containing the TCRα,mb-1, or stromelysin-1
enhancers (Fig. 4a–c). Expression plasmids encoding
an Ets1 splice variant lacking exon VII (p42) or a
S251A/S257A/S282A/S285A mutant (4A), both of
which are incapable of being phosphorylated, were
alsousedas controls (Figs. S1aand10a).Cooperative
transactivation of the TCRα enhancer by wild-type
Ets1 andRunx1was fully preserved in the presence of
CaMKII (T287D), and similar results were obtained
with the p42 or 4A mutant forms of Ets1 (Fig. 4a). In
contrast, co-expression of CaMKII (T287D) significant-
ly reduced cooperative transactivation of the mb-1
enhancer by wild-type Ets1 and Pax5 and of the
stromelysin-1 enhancer by wild-type Ets1. However,
cooperative transactivation was fully preserved when
the p42 or 4A mutant forms of Ets1 were expressed
instead of wild-type Ets1 (Fig. 4b and c). Thus, the
inhibitory effect of Ets1 phosphorylation on transacti-
vation is specifically countered by Runx1 on the TCRα
enhancer.
We also examined the effect of Ets1 and Runx1
mutations on the transactivation of Ets1 target
genes. Note that the tested mutations would impair
either the A or P pathways in the allosteric network
mediating binding cooperativity. Consistent with the
EMSA data, cooperative transactivation by phos-
phorylated Ets1 and Runx1 was reduced by muta-
tion of Ets1 (G333P or P334G) or Runx1 (V170A)
affecting the A pathway or by mutation of Runx1
(R80K) affecting the P pathway (Fig. 4d).
Target gene selection through phosphorylation
of Ets1 in cells
To investigate the effect of Ets1 phosphorylation
on Ets1 binding to TCRα/β andmb-1 enhancers and
to other reported Ets1 target genes [43] in cells, we
performed chromatin immunoprecipitation (ChIP)
analyses in the human Jurkat T cell line and the
mouse WEHI-231 B cell line, following induction of
Ets1 phosphorylation with ionomycin (a Ca2+ionophore) and phosphatase inhibitors (Fig. S10b).
In the absence of ionomycin treatment, enrichment
of Ets1 was observed at all tested Ets1 target genes,
compared with a negative control region (the 3′
region of the albumin gene), in both Jurkat and
WEHI-231 cells (Fig. 5a and b). Following treatment
with ionomycin and phosphatase inhibitors, DNA-
bound Ets1 tended to dissociate from a number of
Ets1 target genes, includingmb-1 in WEHI-231 cells
(Fig. 5a and b). However, Ets1 binding to the TCRα/
β gene was almost completely retained in Jurkat
cells, even after treatment (Fig. 5a). Notably,
although enrichment of Ets1 on the TCRα enhancer
was also detected inWEHI-231 cells, it was reduced
by treatment with ionomycin and phosphatase
inhibitors (Fig. 5b).
We next investigated the expression of several
Ets1 target genes following Ets1 phosphorylation.
The resultant data were essentially consistent with
the ChIP-qPCR (quantitative PCR) data (Fig. S11).
These observations suggest that phosphorylation of
Ets1 alters its target gene repertoire, depending
upon the context of the enhancer and the partner
TFs present (Fig. 5c).Discussion
Allostery is the process by which biological macro-
molecules, such as proteins, transmit information
about the conformational state induced by the binding
of an effector at one site to a different site, enabling the
effector to regulatemolecular function fromadistance.
Previous structural studies for TF–DNA complexes
suggest that the allosteric nature of DNA plays a key
role in the process of assembling TF–DNA complexes
[44,45]. In this study, we focused on the stabilization of
TF assembly, as well as its regulation by phosphor-
ylation of a component via cell signaling, in the context
of protein and DNA allostery.
Widely accepted theories of intermolecular interac-
tions include the conformational selection model and
the induced-fit model. In the conformational selection
model, proteins with intrinsically dynamic natures
achieve molecular recognition by selecting partners
with favorable conformations, from a variety of
conformations in a pre-existing conformational reper-
toire [46,47]. This model is considered to function
predominantly at low ligand concentrations [48].
Based on this model, it is assumed that effector
binding to an allosteric molecule modulates its
conformationally fluctuating space. Thus, the effector
changes the target's conformer distribution, which
affects the dynamic state of a distant critical site to
regulate molecular function.
If the “conformational distribution change” model
[46,47] for allostery is applied to the assembly of TF–
DNA complexes involving Ets1, the equilibrium
relation for Ets1 conformers in the various DNA-
(a)
(d)
(b) (c)
Fig. 4. Cooperative transactivation activities of unphosphorylated and phosphorylated Ets1 with other TFs on three
target gene enhancers. (a–d) Luciferase reporter assays for Ets1 target genes showing transactivation of the TCRα
enhancer thymidine kinase (tk) promoter (a and d), the mb-1 enhancer (b), and the stromelysin-1 enhancer (c) in the
presence (dark gray) and absence (light gray) of constitutively active CaMKII (T287D). Schematic representations of the
reporter constructs with the TFs bound are shown on the top (a–c). In (d), the indicated mutant forms of full-length Ets1 and
Runx1 were used. In all cases, data were calculated as fold activation relative to the reporter-only control and are
presented as means ± SD (n = 3). WT, wild type; *P b 0.05 and **P b 0.01.
1663DNA-mediated allosterycomplexed states is schematically illustrated in
Fig. 6a. In this model, free Ets1 fluctuates between
a major conformer T and two minor conformers, R1
and R2. The inhibitory module is organized in the T
conformer, partly disorganized with disordered HI-1
in the R1 conformer and extensively disorganized in
the R2 conformer. This conformational equilibrium
among T, R1, and R2 becomes shifted toward the T
state upon Ets1 phosphorylation.
In the presence of partner TFs, the R1 and R2
conformers of Ets1 preferentially recognize themb-1
enhancer bound to Pax5 and the TCRα enhancer
bound to Runx1–CBFβ, respectively. The Ets1-
bound stromelysin-1 enhancer is also preferentially
recognized by the R1 conformer. Thus, DNA and
TFs, including Ets1, are considered to behave as
mutually allosteric molecules and effectors (Fig. 6b).
In this study, we demonstrate that Ets1 changes its
target gene repertoire in response to phosphoryla-
tion. We performed detailed structural and molecular
analyses to investigate the molecular mechanisms
underlying this phosphorylation-dependent target
gene selection, from the viewpoint of cooperative
Ets1 binding with its partner TFs on three Ets1 targetenhancers. When bound with Runx1 on the TCRα
enhancer, the R2 conformer of Ets1 forms an
allosterically stabilized complex with a unique
conformational transition mediated by the enhancer
DNA. This is achieved via multiple stabilization
pathways directing a hydrogen bond between a
protein main-chain amide and a DNA backbone
phosphate (Figs. 2c and 6b), which becomes insen-
sitive to the inhibitory effect of Ets1 phosphorylation on
Ets1–DNA binding. In contrast, on the Pax5-bound
mb-1 enhancer or the stromelysin-1 enhancer, theR1
conformer of Ets1 and its partner TF form a DNA
complex with a less extensive interaction network
mediated via a single pathway stabilizing the hydro-
gen bond, which is sensitive to the inhibitory effect of
phosphorylation (Fig. 2d and e).
It is noteworthy that the stability of a common and
characteristic hydrogen bond between a protein
main-chain amide and a DNA backbone phosphate
appears to be critical for allosteric regulation of a
variety of other TF–DNA complexes [2,3,38]. This
suggests that the mechanism for target gene-specific
regulation of Ets1 activity is likely applicable to
regulatory systems involving other TF assemblies on
Fig. 5. ChIP-qPCR analyses of the binding of unphosphorylated and phosphorylated Ets1 to target enhancers in cells.
(a and b) ChIP enrichment values for Ets1 on target enhancers in Jurkat (a) and WEHI-231 (b) cells, in the presence (blue)
and absence (purple) of ionomycin and phosphatase inhibitors (iono. + PTase inh.). ChIP data are presented as
percentages of input (% input) ± SD (n = 3). *P b 0.05 and **P b 0.01. (c) Diagram of the changes in the Ets1 distribution
on target genes induced by CaMKII-catalyzed Ets1 phosphorylation.
1664 DNA-mediated allosterytheir respective target enhancers. Taken together, our
study demonstrates that precise transcriptional mod-
ulation may be attained by chemical modification of
TFs, where allostery involving DNA may play an
important role.
Recently, a direct interaction model between Ets1
and Runx1 on the TCRα enhancer was proposed by
Shrivastava et al. [49]. In their model, a C-terminal
region (190–212) of the Runt domain (50–177)
interacts with Ets1 on the DNA through a missing
loop (178–189) of Runx1, based on their crystal
structures. The position of the N-terminus of the
Ets1-interacting region of Runx1 (Gly190), however,appears spatially too distant from that of the
C-terminus of Runt domain (Arg177) to be connect-
ed through a 13-mer polypeptide corresponding to
the amino acid region 178–189 within a complex.
This raises a question whether the interaction of
Runx1 with Ets1 in their structure would be inter-
complex interaction in the crystal. Because our
EMSA data suggested that the C-terminal region of
the Runt domain enhances the cooperativity with
Ets1 on the TCRα enhancer (Fig. S2), further
structural and functional study will be required to
evaluate the integrity of their direct interaction model
for the cooperativity between Ets1 and Runx1.
Fig. 6. Conformational selection model for Ets1 by a partner within TF–DNA complexes, as well as roles of Ets1, Runx1,
and DNA in the allosteric regulation of their assembly. (a) Three distinct Ets1 conformations observed in structural
analyses are schematically represented with T,R1, andR2 annotations. The Ets1molecule is colored as for Fig. 1. The Ets
domain is depicted as a triangle-like shape, and a helix and a loop within the N-terminal extension of the Ets domain are
shown as a cylinder and a thread. DNA is shown as a gray bamboo-like shape in which the nodes represent the
sugar-phosphate ridges. Runx1 and CBFβ are depicted as ovals, and Pax5 is depicted as two ovals with a thread linker,
each colored as in Fig. 1. (b) Roles of Ets1, Runx1, and DNA in the allosteric regulation of their assembly. Allosteric
effectors and their binding sites are indicated. In the DNA, the allosteric effector Runx1 binding site (the allosteric site) and
the allosteric effector site for Ets1 are shaded dark gray. The red-circled position of the hydrogen bond between L337(NH)
and DNA(PO) corresponds to the critical site for the Ets1–DNA binding regulation. Illustrations of the molecules and the
arrow marks are the same as for (a) and Fig. 2c, respectively.
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1666 DNA-mediated allosteryMaterials and Methods
Protein expression, purification, crystallization, X-ray
diffraction, and structure determination
Sample preparation, crystallization, and cryoprotection of
crystals were performed as previously described (Shiina et
al.). Diffraction data were collected on beamline BL41XU at
SPring-8 (Harima, Japan) and on beamlines BL17A and
NW12A at the Photon Factory at KEK (Tsukuba, Japan).
Detailed protocols for structure determination are described
in Supplementary Methods.
Preparation for phosphorylated fragments of Ets1
Ets1 fragments (276–441) phosphorylated on Ser282
and Ser285 were prepared as described previously [41].
Briefly, recombinant CaMKII was purified from a baculo-
virus expression system, which was kindly provided by
Dr. ThomasSoderling (OregonHealth SciencesUniversity).
Phosphorylation reaction was performed by incubating Ets1
fragments (100 μM at final concentration) for 3 h at 30 °C in
buffer containing 50 mM Hepes-Na (pH 7.5), 10 mM
magnesium acetate, 0.5 mM CaCl2, 1 mM ATP, 2 mM
DTT, 1 μΜ calmodulin, and 0.2 μΜ CaMKII.
Electrophoretic mobility shift assays
Equilibrium constants for protein–DNA interactions
were determined using quantitative EMSAs. DNA fragments
were purified using polyacrylamide gel electrophoresis and
end-labeled with [γ-32P]ATP. DNA binding reactions were
performed in buffer containing 20 mM Tris–HCl (pH 7.2),
150 mM KCl, 1 mg/mL bovine serum albumin, 10 mMDTT,
50 pg/μM poly(dI-dC), 0.005% Tween 20, and 2.5% Ficoll
for 20 min at 4 °C. Increasing concentrations of protein were
incubated with DNA (b1 pM) in reactionmixtures containing
free DNA or pre-formed protein–DNA complexes. Pre-
formed protein–DNA complexes were prepared by mixing
DNA with an appropriate amount of protein, to produce
target complexes including N90% of the total DNA band.
Complexes were resolved on 8% polyacrylamide gels
following electrophoresis at 150 V for 40 min at 4 °C.
Autoradiograms were developed using a Bio-Image analyz-
er BAS 2500 (Fujifilm), and the density of each band was
quantified using ImageGauge v. 4.23 software (Fujifilm).
Equilibrium dissociation constants (KD) were determined by
plotting the proportion of protein-boundDNA in the total DNA
([Protein–DNA (PD)]/[Total DNA (Dt)]) against the protein
concentration ([P]) as previously described [29]. KD values
and standard errors were calculated using nonlinear
least-squares fitting of the average values from three data
points to [PD]/[Dt] = 1/(1 + (KD/[P])) using the gnuplot
software package. To evaluate cooperative DNA binding
of proteinsA andB,weplotteda super-shifted band (PAPBD)
obtained by titration of protein A against the protein B–DNA
complex (PBD) against the protein A concentration [PA].
Data were then fitted to the following model: [PAPBD]/[Dt] =
1/(1 + (KD/[PA])), where [Dt] = [PBD] + [PAPBD], ignoring
free DNA [D]. DNA binding affinities are presented as
equilibrium association constant (KA) values, the inverse of
the KD values.Luciferase reporter assays
Luciferase reporter constructs were prepared by subclon-
ing the minimal human TCRα enhancer (position 12–109)
[16], the human mb-1 enhancer (position −525/+26) [50],
and the human stromelysin-1 enhancer (position −478/+4)
[51], upstream of the luciferase gene in the pGL3 basic
vector (Promega). HeLa and HEK293T cells were cultured
in Dulbecco's modified Eagle's medium supplemented with
10% fetal calf serum. The cells were transiently co-trans-
fected with the appropriate reporter plasmid and expression
plasmids pCG-Ets1, pCAGGS-Runx1, pEF-BOS-CBFβ, or
pcDNA3.1-Pax5, encoding full-length human Ets1 (1–441),
mouse Runx1 isoform 1 (1–451), mouse CBFβ (1–187), or
mouse Pax5 (1–391), respectively, in the presence or
absence of pSRalpha.BKS-CaMKII(T287D) [24,42],
which encodes a constitutively active human CaMKII
(T287D) mutant. DNA transfection was performed using
PolyFect (Qiagen) or Lipofectamine 2000 (Invitrogen) in
accordance with the manufacturer's instructions. Luciferase
activity was assayed using the dual-luciferase reporter
assay system (Promega) with a Berthold-designed
luminometer (Centro LB960) according to the manufac-
turer's instructions.
Data are expressed as fold activation relative to the
reporter-only control and represent the mean ± SD (n = 4).
Statistical significance was evaluated using an unpaired,
two-tailed t test.
ChIP assay
Jurkat and WEHI-231 cells were purchased from the
American Type Culture Collection and cultured in accor-
dance with the supplier's instructions. For induction of
Ets1 phosphorylation, cells were treated with ionomycin
(1 μg/mL) and a cocktail of phosphatase inhibitors including
sodium orthovanadate (1 mM), β-glycerophosphate
(10 mM), and NaF (10 mM) for 30 min (Jurkat cells) or
15 min (WEHI-231 cells) at 37 °C under a 5% CO2
atmosphere. The phosphorylation reaction was terminated
by formaldehyde cross-linking for 15 min at room tempera-
ture (25 °C).
ChIP assays were performed as previously described
[43]. Briefly, Dynabeads were conjugated with anti-Ets1
rabbit immunoglobulin G (sc-350; Santa Cruz Biotechnol-
ogy, Inc.) or control rabbit immunoglobulin G (Santa Cruz
Biotechnology, Inc.). Nuclei were isolated from 1.0 × 107
cells and chromatin was sonicated for 30 min at 4 °C in
250 μL of nuclear lysis buffer [50 mM Tris–HCl (pH 7.9),
10 mM ethylenediaminetetraacetic acid (EDTA), 1% SDS,
and 1× protease inhibitor cocktail (Roche)] using a
Bioruptor (Cosmo Bio). Chromatin extracts were incubated
with Dynabeads for 6 h at 4 °C on a rotating wheel.
Dynabeads were then washed with immunoprecipitation
wash buffer [20 mM Tris–HCl (pH 7.9), 0.25% NP-40,
0.005% SDS, 2 mM EDTA, and 250 mM NaCl] (3×, 5 min)
at 4 °C, followed by TE buffer [10 mM Tris–HCl (pH 8.0)
and 1 mM EDTA] containing 50 mM NaCl (1×, 5 min) at
4 °C. The beadswere then resuspended in 100 μL TE buffer
containing RNase (100 μg/mL) and incubated for 30 min at
37 °C. SDS (1% w/v) and proteinase K (100 μg/mL) were
subsequently added to the bead slurry and samples were
incubated for 3 h at 55 °C and subsequently for 8 h at
65 °C. The immunoprecipitated DNA was extracted using
1667DNA-mediated allosteryphenol/chloroform and purified using a PCR purification
kit (Qiagen).
Real-time PCR
Real-time PCR was performed using SYBR Premix
DimerEraser (TaKaRa) with a LightCycler 480 Real-Time
PCR System (Roche). PCR primers targeting human Ets1
binding sites, the 3′ region of the human albumin gene (as
a negative control), and the mouse IP3R3 enhancer were
previously described [43,52]. Primer sequences for the
mousemb-1 enhancer, mouse TCRα enhancer, and the 3′
region of the mouse albumin gene were designed using
Primer3Plus and are as follows: mb-1 forward 5′-CACC
TCTCAGGGGAATTGTG-3′, reverse 5′-ACCAGATCCC
TACCCCAAAC-3′; TCRα forward 5′-CCAGAAGTAGAA
CAGGAAATGGA-3′, reverse 5′-TTTCCAGAGGATGTGG
CTTC-3′; albumin 3′ ORF forward 5′-TACAGCGGAGCA
ACTGAAGA-3 ′, reverse 5 ′-GACCACGTGCACAG
AAAATG-3′. The ChIP data are presented as percentages
of input (% input) and represent the mean of three
independent experiments ± SD. Statistical significance
was evaluated using an unpaired, two-tailed t test.
Accession codes
Atomic coordinates and structure factors for the reported
structures have been deposited with the Protein Data Bank
under accession codes 3WTS (Ets1–Runx1–CBFβ–DNA
complex), 3WTT (phosphorylated Ets1–Runx1–CBFβ–
DNA complex), 3WTU [Ets1–Runx1(V170A)–CBFβ–DNA
complex], 3WTX [Ets1(Y329A)–Runx1–CBFβ–DNA
complex], and 3WTY [Ets1(G333P)–Runx1–CBFβ–DNA
complex].ethylenediaminetetraacetic acid.Acknowledgments
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